Review of treatment assessment using DCE-MRI in breast cancer radiation therapy.
暂无分享,去创建一个
Fang-Fang Yin | Zheng Chang | F. Yin | Z. Chang | J. Horton | Chunhai Wang | Janet Horton | Chun-Hao Wang | Z. Chang
[1] F. Yin,et al. SU‐E‐CAMPUS‐J‐04: Evaluating Radiation‐Induced Changes with Diffusion Weighted MRI and Dynamic Contrast Enhanced MRI in Patients with Early Stage Breast Cancer Treated with Stereotactic Body Radiotherapy: Initial Results , 2013 .
[2] Yu-Han H. Hsu,et al. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. , 2013, Magnetic resonance imaging.
[3] Philippe Lambin,et al. Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.
[4] Mario Sansone,et al. Dynamic contrast-enhanced MRI in breast cancer: A comparison between distributed and compartmental tracer kinetic models , 2012 .
[5] Xia Li,et al. Statistical comparison of dynamic contrast‐enhanced MRI pharmacokinetic models in human breast cancer , 2012, Magnetic resonance in medicine.
[6] Sarah J Nelson,et al. Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI , 2011, NMR in biomedicine.
[7] F. Beuvon,et al. Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.
[8] N. deSouza,et al. Functional magnetic resonance: biomarkers of response in breast cancer , 2011, Breast Cancer Research.
[9] Jieru Chi,et al. GPU-Accelerated FDTD Modeling of Radio-Frequency Field–Tissue Interactions in High-Field MRI , 2011, IEEE Transactions on Biomedical Engineering.
[10] various,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology , 2011 .
[11] Lucy E Kershaw,et al. Temporal resolution and SNR requirements for accurate DCE‐MRI data analysis using the AATH model , 2010, Magnetic resonance in medicine.
[12] G S Karczmar,et al. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study , 2010, Physics in medicine and biology.
[13] Qiang He,et al. Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory. , 2010, Medical physics.
[14] M. Giger,et al. Multimodality computer-aided breast cancer diagnosis with FFDM and DCE-MRI. , 2010, Academic radiology.
[15] Jong Hyo Kim,et al. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI. , 2010, Medical physics.
[16] Justin P. Haldar,et al. Accelerating iterative field-compensated MR image reconstruction on GPUs , 2010, 2010 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[17] L. Christiansen,et al. A variant in the fat mass and obesity-associated gene (FTO) and variants near the melanocortin-4 receptor gene (MC4R) do not influence dietary intake. , 2010, The Journal of nutrition.
[18] Johannes Buurman,et al. The influence of temporal resolution in determining pharmacokinetic parameters from DCE‐MRI data , 2010, Magnetic resonance in medicine.
[19] T W Redpath,et al. The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T , 2010, Physics in medicine and biology.
[20] Fiona J Gilbert,et al. B1 transmission‐field inhomogeneity and enhancement ratio errors in dynamic contrast‐enhanced MRI (DCE‐MRI) of the breast at 3T , 2010, Journal of magnetic resonance imaging : JMRI.
[21] M. Heisen. Understanding quantitative DCE-MRI of the breast : towards meaningful clinical application , 2010 .
[22] A. C.A.. The effectiveness of a bisagittal power optimisationapproach in the reduction of B1 inhomogenity in breastMRI at 3T. , 2009 .
[23] L. Schwartz,et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[25] Maximilian Reiser,et al. Quantification of cerebral blood flow, cerebral blood volume, and blood–brain‐barrier leakage with DCE‐MRI , 2009, Magnetic resonance in medicine.
[26] Wendie A Berg,et al. Tailored supplemental screening for breast cancer: what now and what next? , 2009, AJR. American journal of roentgenology.
[27] Glen R Morrell,et al. Uncertainty in T1 mapping using the variable flip angle method with two flip angles , 2009, Physics in medicine and biology.
[28] L. Turnbull. Dynamic contrast‐enhanced MRI in the diagnosis and management of breast cancer , 2009, NMR in biomedicine.
[29] Guang-Zhong Yang,et al. Quantitative Analysis of Dynamic Contrast-Enhanced MR Images Based on Bayesian P-Splines , 2008, IEEE Transactions on Medical Imaging.
[30] D. Parker,et al. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences , 2008, Physics in medicine and biology.
[31] Justin P. Haldar,et al. Accelerating advanced mri reconstructions on gpus , 2008, CF '08.
[32] E. Rofstad,et al. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. , 2008, Magnetic resonance imaging.
[33] Nacim Betrouni,et al. Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results , 2008, International Journal of Computer Assisted Radiology and Surgery.
[34] F. Vicini,et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. , 2007, American journal of surgery.
[35] Hans H Schild,et al. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. , 2007, Radiology.
[36] G. Newstead,et al. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. , 2007, Magnetic resonance imaging.
[37] Hai-Ling Margaret Cheng,et al. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1‐weighted DCE‐MRI , 2007, Journal of magnetic resonance imaging : JMRI.
[38] Thomas E Yankeelov,et al. Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE‐MRI data , 2007, Magnetic resonance in medicine.
[39] G. Parker,et al. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.
[40] Mariko Goto,et al. Diagnosis of breast tumors by contrast‐enhanced MR imaging: Comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features , 2007, Journal of magnetic resonance imaging : JMRI.
[41] Evis Sala,et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. , 2007, The Lancet. Oncology.
[42] Thomas E Yankeelov,et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.
[43] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[44] N. Hylton. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] Jürgen Gieseke,et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. , 2006, Radiology.
[46] A. Jackson,et al. Comparative study into the robustness of compartmental modeling and model‐free analysis in DCE‐MRI studies , 2006, Journal of magnetic resonance imaging : JMRI.
[47] G. Wright,et al. Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.
[48] John Suckling,et al. Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[49] Kevin Camphausen,et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] A. Luini,et al. The Pilot Trial on Intraoperative Radiotherapy with Electrons (ELIOT): Update on the Results , 2005, Breast Cancer Research and Treatment.
[51] Richard D Penn,et al. Full‐brain T1 mapping through inversion recovery fast spin echo imaging with time‐efficient slice ordering , 2005, Magnetic resonance in medicine.
[52] Ralf Deichmann,et al. Fast high‐resolution T1 mapping of the human brain , 2005, Magnetic resonance in medicine.
[53] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[54] T W Redpath,et al. The use of the Levenberg–Marquardt curve-fitting algorithm in pharmacokinetic modelling of DCE-MRI data , 2005, Physics in medicine and biology.
[55] J. Gore,et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.
[56] Wei Huang,et al. Evidence for shutter‐speed variation in CR bolus‐tracking studies of human pathology , 2005, NMR in biomedicine.
[57] Bradford A Moffat,et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] James H Thrall,et al. Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.
[59] Vladimir Bilim,et al. Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is a useful modality for the precise detection and staging of early prostate cancer , 2005, The Prostate.
[60] Geoffrey J. M. Parker,et al. Tracer Kinetic Modelling for T1-Weighted DCE-MRI , 2005 .
[61] A. Padhani,et al. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging , 2005, Abdominal Imaging.
[62] D. Roses,et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. , 2004, International journal of radiation oncology, biology, physics.
[63] J. Jesberger,et al. Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cance , 2004 .
[64] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[65] Joanna Leadbetter,et al. Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126 , 2004, Clinical Cancer Research.
[66] Xiaobing Fan,et al. New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors , 2004, Magnetic resonance in medicine.
[67] D. Gianfelice,et al. MR Imaging-guided Focused Ultrasound Surgery of Breast Cancer: Correlation of Dynamic Contrast-enhanced MRI with Histopathologic Findings , 2003, Breast Cancer Research and Treatment.
[68] J. Waterton,et al. Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126 , 2004, Clinical Cancer Research.
[69] Daniele Regge,et al. Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging , 2004, Breast Cancer Research and Treatment.
[70] I. Choi,et al. p38 Mitogen‐activated protein kinase modulates expression of tumor necrosis factor‐related apoptosis‐inducing ligand induced by interferon‐γ in fetal brain astrocytes , 2003, Journal of neuroscience research.
[71] Thomas E Yankeelov,et al. Variation of the relaxographic “shutter‐speed” for transcytolemmal water exchange affects the CR bolus‐tracking curve shape , 2003, Magnetic resonance in medicine.
[72] Orhan Nalcioglu,et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer , 2003, Journal of magnetic resonance imaging : JMRI.
[73] Martin A Lodge,et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] B. Rutt,et al. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state , 2003, Magnetic resonance in medicine.
[75] A. Padhani. MRI for assessing antivascular cancer treatments. , 2003, The British journal of radiology.
[76] A. Padhani,et al. Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.
[77] K. Brindle,et al. Differential sensitivity of two adenocarcinoma xenografts to the anti‐vascular drugs combretastatin A4 phosphate and 5,6‐dimethylxanthenone‐4‐acetic acid, assessed using MRI and MRS , 2002, NMR in biomedicine.
[78] David L Buckley,et al. Uncertainty in the analysis of tracer kinetics using dynamic contrast‐enhanced T1‐weighted MRI , 2002, Magnetic resonance in medicine.
[79] P J Drew,et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[80] A Heerschap,et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors , 2001, Journal of magnetic resonance imaging : JMRI.
[81] M. Knopp,et al. Dynamic contrast‐enhanced MRI using Gd‐DTPA: Interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors , 2001, Magnetic resonance in medicine.
[82] Peter Jezzard,et al. Rapid T1 mapping using multislice echo planar imaging , 2001, Magnetic resonance in medicine.
[83] R. Matsubayashi,et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. , 2000, Radiology.
[84] W. Rooney,et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange , 2000, Magnetic resonance in medicine.
[85] G M Tozer,et al. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. , 2000, European journal of cancer.
[86] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[87] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[88] A. Marmarou,et al. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.
[89] Egill Rostrup,et al. Capillary transfer constant of Gd‐DTPA in the myocardium at rest and during vasodilation assessed by MRI , 1998, Magnetic resonance in medicine.
[90] Ting-Yim Lee,et al. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[91] G. Glover,et al. Breast disease: dynamic spiral MR imaging. , 1998, Radiology.
[92] B K Rutt,et al. Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.
[93] P. Vaupel,et al. Tumor hypoxia in pelvic recurrences of cervical cancer , 1998, International journal of cancer.
[94] A. Waites,et al. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? , 1998, Advances in enzyme regulation.
[95] D B Kopans,et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. , 1997, Radiology.
[96] D S Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[97] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[98] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[99] L D Buadu,et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.
[100] P. Stomper,et al. Invasive breast carcinoma: Analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S‐phase percentage , 1996 .
[101] P. Stomper,et al. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. , 1996, Cancer.
[102] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[103] R. Steen,et al. Precise and accurate measurement of proton T1 in human brain in vivo: Validation and preliminary clinical application , 1994, Journal of magnetic resonance imaging : JMRI.
[104] B Asselain,et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. , 1993, Radiology.
[105] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[107] P. Mansfield,et al. High‐speed multislice T1 mapping using inversion‐recovery echo‐planar imaging , 1990, Magnetic resonance in medicine.
[108] B. Bonnemain,et al. Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers. , 1990, Investigative radiology.
[109] K. B. Larson,et al. Tracer-Kinetic Models for Measuring Cerebral Blood Flow Using Externally Detected Radiotracers , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[110] J. J. Moré,et al. Levenberg--Marquardt algorithm: implementation and theory , 1977 .
[111] R. Kallman,et al. Oxygen effect and reoxygenation , 1975 .